Log In
BCIQ
Print this Print this
 

TREM-1

  Manage Alerts
Collapse Summary General Information
Company Novo Nordisk A/S
DescriptionCompound targeting triggering receptors expressed on myeloid cells 1 (TREM1)
Molecular Target Triggering receptor expressed on myeloid cells 1 (TREM1)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationSepsis
Indication DetailsTreat sepsis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today